Press "Enter" to skip to content

Zydus receives final nod from USFDA to market Acetazolamide injection

The company has received final approval from the United States Food and Drug Administration (USFDA) to market Acetazolamide for injection 500 mg per single-dose vial, Zydus Cadila said in a filing to BSE.

Also Read:   Second U.S. judge blocks Trump administration birth control rules